Molecular mechanisms and therapeutic target of NETosis in diseases
J Huang, W Hong, M Wan, L Zheng - MedComm, 2022 - Wiley Online Library
Evidence shows that neutrophils can protect the host against pathogens in multiple ways,
including the formation and release of neutrophil extracellular traps (NETs). NETs are web …
including the formation and release of neutrophil extracellular traps (NETs). NETs are web …
The role of cytokines in neutrophil development, tissue homing, function and plasticity in health and disease
M Tsioumpekou, D Krijgsman, JHW Leusen… - Cells, 2023 - mdpi.com
Neutrophils are crucial innate immune cells and comprise 50–70% of the white blood cell
population under homeostatic conditions. Upon infection and in cancer, blood neutrophil …
population under homeostatic conditions. Upon infection and in cancer, blood neutrophil …
The redox protein high-mobility group box 1 in cell death and cancer
Significance: As a redox-sensitive protein, high-mobility group box 1 (HMGB1) is implicated
in regulating stress responses to oxidative damage and cell death, which are closely related …
in regulating stress responses to oxidative damage and cell death, which are closely related …
Role of neutrophil extracellular traps in health and disease pathophysiology: recent insights and advances
MM Islam, N Takeyama - International Journal of Molecular Sciences, 2023 - mdpi.com
Neutrophils are the principal trouper of the innate immune system. Activated neutrophils
undergo a noble cell death termed NETosis and release a mesh-like structure called …
undergo a noble cell death termed NETosis and release a mesh-like structure called …
Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma
R Kong, W Wei, Q Man, L Chen, Y Jia, H Zhang, Z Liu… - Cancer Letters, 2023 - Elsevier
Hepatocellular carcinoma (HCC) is often associated with poor outcomes due to lung
metastasis. ICAM-1+ circulating tumor cells, termed circulating cancer stem cells (CCSCs) …
metastasis. ICAM-1+ circulating tumor cells, termed circulating cancer stem cells (CCSCs) …
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
A Bocanegra, G Fernández‐Hinojal, D Ajona… - EMBO …, 2023 - embopress.org
Recent studies highlight the importance of baseline functional immunity for immune
checkpoint blockade therapies. High‐dimensional systemic immune profiling is performed in …
checkpoint blockade therapies. High‐dimensional systemic immune profiling is performed in …
Neutrophil extracellular traps: New players in cancer research
J Zhao, J Jin - Frontiers in immunology, 2022 - frontiersin.org
NETs are chromatin-derived webs extruded from neutrophils as a result of either infection or
sterile stimulation using chemicals, cytokines, or microbes. In addition to the classical role …
sterile stimulation using chemicals, cytokines, or microbes. In addition to the classical role …
Complement C5a induces the generation of neutrophil extracellular traps by inhibiting mitochondrial STAT3 to promote the development of arterial thrombosis
Y Chen, X Li, X Lin, H Liang, X Liu, X Zhang… - Thrombosis …, 2022 - Springer
Background Thrombotic events cannot be completely prevented by antithrombotics,
implicating a therapeutic gap due to inflammation, a not yet sufficiently addressed …
implicating a therapeutic gap due to inflammation, a not yet sufficiently addressed …
NETosis: sculpting tumor metastasis and immunotherapy
Y Hu, H Wang, Y Liu - Immunological Reviews, 2024 - Wiley Online Library
The process of neutrophil extracellular traps (NETs) formation, called NETosis, is a peculiar
death modality of neutrophils, which was first observed as an immune response against …
death modality of neutrophils, which was first observed as an immune response against …
The receptor for Advanced Glycation endproducts (RAGE) and its ligands S100A8/A9 and high mobility Group Box protein 1 (HMGB1) are key regulators of myeloid …
S Ostrand-Rosenberg, T Huecksteadt, K Sanders - Cancers, 2023 - mdpi.com
Simple Summary Cancer immunotherapies using antibodies and genetically modified T
cells are effective in a subset of cancer patients. However, many cancer patients do not …
cells are effective in a subset of cancer patients. However, many cancer patients do not …